Call For Papers

Enzymes are critical biological catalysts that govern a wide variety of physiological functions and cellular processes. The dysregulation of different enzymatic processes is related to different diseases, cell proliferation and cancer progression, and metastasis. Therefore, targeting an enzyme in a particular disease or cancer, and designing a PDT, anticancer, or ... Submit Now

Hypertension is the primary cause of cardiovascular diseases and is responsible for nearly 9 million deaths worldwide annually. Increasing evidence indicates that in addition to pathophysiologic processes, the environmental factors, such as geographic location, lifestyle choices, socioeconomic status, and cultural practices, influence the risk, progression, and severity of hypertension. This ... Submit Now

Pharmaceutical innovation has historically relied on natural products as a foundation, providing scaffolds for drug discovery that are both physiologically active and physically diverse. Advances in synthetic biology, analytical chemistry, and computational modelling have rekindled the hunt for natural lead compounds from marine, microbial, and plant sources in the modern ... Submit Now

Natural products have long served as a rich source of bioactive compounds and remain central to drug discovery. Despite technological advancements such as high-throughput synthesis, combinatorial chemistry, and computer-aided drug design, natural products continue to inspire new drug development due to their structural diversity and wide range of biological activities, ... Submit Now

Brain injury and neurodegenerative diseases represent a continuum of neurological dysfunction marked by progressive cellular damage, impaired neuroplasticity, and cognitive decline. Although traditionally considered distinct, mounting evidence reveals shared pathophysiological mechanisms—including oxidative stress, mitochondrial dysfunction, excitotoxicity, and chronic neuroinflammation—that contribute to both acute and chronic neural deterioration. This special issue ... Submit Now

The evolving landscape of medicinal chemistry is increasingly influenced by the urgent need to reconcile human health priorities with sustainability imperatives and economic feasibility. While drug discovery and therapeutic development pipelines lead to substantive scientific outcomes, they nonetheless remain disproportionately resource-intensive, environmentally taxing, and financially enclosed. In response to these ... Submit Now

The scope of this project encompasses several cutting-edge areas at the intersection of artificial intelligence and oncology. First, it involves developing AI models for drug response prediction and biomarker discovery, enabling more accurate and personalized treatment strategies. Second, it focuses on predictive models for mental health outcomes in cancer patients, ... Submit Now

Over the past decade, small-molecule drugs have remained the dominant force among approved therapeutics. Recent advances in artificial intelligence and structural biology now enable researchers to discover novel targets for small molecule inhibitors with greater precision and to pursue rational drug design, markedly accelerating the development of new small molecule ... Submit Now

Nutraceuticals have emerged as vital contributors to health promotion, disease prevention, and sustainable nutrition, offering opportunities that bridge food, medicine, and public health. Despite significant progress in the isolation and characterization of bioactive compounds, challenges remain in translating laboratory findings into clinical practice and real-world applications. This thematic issue will ... Submit Now

The rapid evolution of artificial intelligence (AI) is transforming the way we design, discover, and utilize advanced materials. In particular, the integration of AI with smart materials—materials that can sense, adapt, and respond to their environment opens up new frontiers in science, engineering, and technology. This synergy has the potential ... Submit Now

The special issue titled “Sustainability & Emerging Technologies: Cross-Sector Innovations in Healthcare, Agriculture, and Climate Resilience”, aims to explore how advanced technologies can address urgent global sustainability challenges across multiple critical domains. Healthcare, agriculture, and climate resilience are deeply interconnected sectors where technological innovation has the potential to drive transformative ... Submit Now

Alzheimer’s Disease (AD) is one of the highly prevalent, most complex, and destructive neurodegenerative disorders. Complete cure of the disease is still illusive and treatment still involves symptomatic therapeutic interventions. The critical challenges, like penetration of the blood-brain barrier (BBB), targeted delivery of active molecules and scaffolds, and off-target toxicity, ... Submit Now